ABCL
AbCellera Biologics Inc [ABCL] Revenue clocked in at $35.32 million, up 28.68% YTD: What’s Next?
AbCellera Biologics Inc [NASDAQ: ABCL] closed the trading session at $3.41 on 2025-11-20. The day’s price range saw the stock ...
AbCellera Biologics Inc [ABCL] gain 14.92% so far this year. What now?
AbCellera Biologics Inc [NASDAQ: ABCL] price plunged by -8.82 percent to reach at -$0.35. A sum of 7093881 shares traded ...
AbCellera Biologics Inc [ABCL] stock Resumed by Leerink Partners analyst, price target now $5
AbCellera Biologics Inc [NASDAQ: ABCL] price plunged by -3.70 percent to reach at -$0.18. A sum of 5965635 shares traded ...
Wall Street Analyst Resumed AbCellera Biologics Inc [ABCL]. What else is Wall St. saying
AbCellera Biologics Inc [NASDAQ: ABCL] jumped around 0.48 points on Wednesday, while shares priced at $6.1 at the close of ...
Market cap of AbCellera Biologics Inc [ABCL] reaches 1.84B – now what?
AbCellera Biologics Inc [NASDAQ: ABCL] traded at a high on 2025-10-08, posting a 6.93 gain after which it closed the ...
AbCellera Biologics Inc [ABCL] Stock trading around $5.96 per share: What’s Next?
AbCellera Biologics Inc [NASDAQ: ABCL] stock went on an upward path that rose over 18.49% on Wednesday, amounting to a ...
AbCellera Biologics Inc [ABCL] gain 78.83% so far this year. What now?
AbCellera Biologics Inc [NASDAQ: ABCL] gained 1.45% on the last trading session, reaching $4.9 price per share at the time. ...
